8.52050

Fmoc-Trp(Boc)-OH

Novabiochem^®

• 别名: Fmoc-Trp(Boc)-OH, N-α-Fmoc-N-in-t.-Boc-L-tryptophan
• 经验公式（希尔记法）: C₃₁H₃₀N₂O₆
• CAS号: 143824-78-6
• 分子量: 526.58
• MDL號碼: MFCD00153366
• 分類程式碼代碼: 12352209
• NACRES: NA.22

属性

• 品質等級: 300
• 產品線: Novabiochem^®
• 化驗: ≥90.0% (acidimetric); ≥97.5% (HPLC); ≥98% (TLC)
• 形狀: powder
• 反應適用性: reaction type: Fmoc solid-phase peptide synthesis
• 製造商／商標名: Novabiochem^®
• 應用: peptide synthesis
• 官能基: Boc; Fmoc
• 儲存溫度: 15-25°C
• InChI: 1S/C31H30N2O6/c1-31(2,3)39-30(37)33-17-19(20-10-8-9-15-27(20)33)16-26(28(34)35)32-29(36)38-18-25-23-13-6-4-11-21(23)22-12-5-7-14-24(22)25/h4-15,17,25-26H,16,18H2,1-3H3,(H,32,36)(H,34,35)/t26-/m0/s1
• InChI 密鑰: ADOHASQZJSJZBT-SANMLTNESA-N

说明

一般說明

High purity Fmoc-protected amino acid for research and process production of peptides, with very low levels of dipeptide, free-amino acids and acetic acid impurities.
The use of this N-in-Boc protected derivative overcomes most of the problems associated with the preparation of Trp containing-peptides by Fmoc SPPS ^[1]. Cleavage with TFA generates an N-in-carboxy indole which protects the Trp from alkylation ^[1,2,3] and sulfonation ^[1,4,5,6,7]. The N-in-carboxy group is removed under aqueous conditions during normal work-up of the peptide.

Associated Protocols and Technical Articles
Fmoc-amino acids for Peptide Production
Cleavage and Deprotection Protocols for Fmoc SPPS

Literature references

^[1] P. White in ′Peptides, Chemistry & Biology, Proc. 12th American Peptide Symposium′, J. A. Smith & J. E. Rivier (Eds), ESCOM, Leiden, 1992, pp. 537.
^[2] B. Riniker, et al. (1993) Tetrahedron, 49, 9307.
^[3] T. Johnson, et al. (1993) J. Chem. Soc., Chem. Commun., 369.
^[4] H. Choi, et al. (1993) Int. J. Peptide Protein Res., 42, 58.
^[5] C. G. Fields, et al. (1993) Tetrahedron Lett., 34, 6661.
^[6] T. Lescrinier, et al. (1995) Lett. Pept. Sci., 2, 225.
^[7] M. Noda & M. Kiffe (1997) J. Peptide Res., 50, 329.

應用

• Highly active antibacterial ferrocenoylated or ruthenocenoylated Arg-Trp peptides can be discovered by an L-to-D substitution scan: Utilizes Fmoc-Trp(Boc)-OH in the synthesis of peptides designed to enhance antibacterial activity, demonstrating its role in the development of new antimicrobial agents (Albada et al., 2014).


• Nanoparticles generated from a tryptophan derivative: physical characterization and anti-cancer drug delivery: Explores the use of Fmoc-Trp(Boc)-OH in nanoparticle formation for targeted drug delivery systems, particularly in cancer therapy (Dube et al., 2017).

聯結

Replaces: 04-12-1103

分析報告

Colour (visual): white to off white
Appearance of substance (visual): powder
Colour index (0,5 M in DMF): ≤ 150 Hazen
Identity (IR): passes test
Enantiomeric purity: ≥ 99.7 % (a/a)
Purity (HPLC): ≥ 97.5 % (a/a)
Fmoc-ß-Ala-OH (HPLC): ≤ 0.3 % (a/a)
Fmoc-ß-Ala-Trp (Boc)-OH (HPLC): ≤ 0.1 % (a/a)
Fmoc-Trp(Boc)-Trp(Boc)-OH (HPLC): ≤ 0.1 % (a/a)
Fmoc-Trp-OH (HPLC): ≤ 1.0 % (a/a)
Assay free amino acid (HPLC): ≤ 0.2 %
Solubility (25 mmole in 50 ml DMF): clear soluble
Purity (TLC(011A)): ≥ 98 %
Purity (TLC(0811)): ≥ 98 %
Assay (acidimetric): ≥ 90.0 %
Water (K. F.): ≤ 2.0 %
Ethyl acetate (HS-GC): ≤ 2.5 %
Acetate (IC): ≤ 0.10 %

To see the solvent systems used for TLC of Novabiochem^® products please click here.

法律資訊

Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany

安全信息

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable